Ganka Bineva‐Todd

The Francis Crick Institute

Papers

1

Total Citations

14

H-Index

1

About

Dr. Ganka Bineva‐Todd is a researcher whose work sits at the critical intersection of virology, public health, and high-throughput diagnostics. Her most cited study, "Scalable and Resilient SARS-CoV-2 testing in an Academic Centre" (2020, 14 citations), was a direct response to the unprecedented challenges of the COVID-19 pandemic. This work detailed a robust, adaptable framework for establishing large-scale testing within an academic setting, a contribution that proved vital for protecting healthcare workers and managing institutional outbreaks during a global crisis. By addressing the critical shortage of testing capacity, her research provided a practical blueprint for resilience and rapid response. While her citation count reflects the immediate, applied nature of this pivotal work, its impact is measured in lives and institutional stability. Dr. Bineva‐Todd’s expertise in developing scalable solutions under pressure underscores her significant role in pandemic preparedness and operational virology, making her a key figure in translating scientific methodology into real-world, life-saving action.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Scalable and Resilient SARS-CoV-2 testing in an Academic Centre
14 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 79
🏛 Institutions: The Francis Crick Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago